Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status

Leukemia & Lymphoma
Soo-Zin KimEckhart Weidmann

Abstract

The mutational status of immunoglobulin variable region genes (Ig VH) is a well established prognostic parameter in chronic lymphocytic leukemia (CLL). Recently, a subset of genes with a characteristic expression profile correlating with the mutational status of B-CLLs has been identified. One of the overexpressed genes in the prognostically unfavorable group of CLL patients with unmutated Ig VH genes encodes for the protein tyrosine kinase ZAP-70, which is physiologically involved in T-cell signaling. Since ZAP-70 has been described to be prognostically relevant in CLL, we analyzed the possible relationship of its expression to the mutational status of Ig VH genes as well as to other prognostic factors in CLL and indolent lymphomas. The mutational status of Ig VH genes was analyzed by seminested PCR, direct sequencing and comparison with the sequences of the EMBL databases in 60 samples of patients with B-CLL and 18 samples of patients with indolent B-cell malignancies. ZAP-70 protein expression was assessed in all samples by immunoblotting and for semiquantitative analysis the ratio of ZAP-70 to tubulin expression was calculated. ZAP-70 protein was found to be expressed in all investigated B-cell malignancies. Expression leve...Continue Reading

References

May 1, 1994·The Journal of Experimental Medicine·T KurosakiH Yamamura
Jan 3, 2001·The New England Journal of Medicine·H DöhnerP Lichter
Apr 23, 2003·Immunity·Edina SchweighofferVictor L J Tybulewicz
May 2, 2003·The New England Journal of Medicine·Marta CrespoEmili Montserrat
Jan 17, 2004·Lancet·Jenny A OrchardDavid G Oscier

❮ Previous
Next ❯

Citations

Oct 20, 2006·Cancer Immunology, Immunotherapy : CII·Amal MansourElizabeth Raveche
Nov 15, 2007·Cytogenetic and Genome Research·F E Cotter, R L Auer
Jul 16, 2005·Leukemia & Lymphoma·Youli ZuUNKNOWN Pathology Panel of the Lymphoma/Leukemia Molecular Profiling Project
Dec 3, 2005·Leukemia & Lymphoma·Claudia VenerGiorgio Lambertenghi Deliliers
Nov 3, 2005·Leukemia & Lymphoma·Jenny OrchardDavid Oscier
Aug 15, 2006·Cytometry. Part B, Clinical Cytometry·Mark Shenkin, Russell Maiese
Jan 15, 2008·International Journal of Laboratory Hematology·B T ChaarL E Grosso
Sep 7, 2007·Annals of the New York Academy of Sciences·Amani MankaïAnne Bordron
Sep 18, 2007·Annals of Diagnostic Pathology·Kedar V Inamdar, Carlos E Bueso-Ramos
Dec 9, 2016·The Journal of Gene Medicine·Juan Luis Fernández-MartínezStephen T Sonis
Jul 27, 2007·American Journal of Hematology·J Brice WeinbergMarc C Levesque
Aug 1, 2020·The Cochrane Database of Systematic Reviews·Nina KreuzbergerNicole Skoetz
Dec 8, 2006·Archives of Pathology & Laboratory Medicine·Zahid Kaleem
Mar 10, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I HusA Dmoszyńska

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.